Navigation Links
Preventice Expands Options for Wireless Patient Monitoring with Qualcomm Life
Date:5/24/2012

MINNEAPOLIS, May 24, 2012 /PRNewswire/ -- Preventice, Inc., a developer of mobile health applications and patient monitoring systems, announced today that it is the latest to join medical device manufacturers, application developers, health care services companies and payors that are integrating with Qualcomm Life Inc., a wholly owned subsidiary of Qualcomm Incorporated, and their 2net™ Ecosystem.

(Logo: http://photos.prnewswire.com/prnh/20120417/CG89172LOGO)

Preventice is a break-through developer of mobile health applications with an emphasis on remote patient monitoring systems that deliver continuous care. Preventice's cutting-edge solutions allow individuals to remain active and independent while their individual physiologic characteristics are being monitored with a simple and discreet body-worn sensor. Preventice will leverage Qualcomm Life's 2net Platform in order to provide chronic care patients with multiple remote connectivity options.

"Our work with Qualcomm Life supports the Preventice mobile health strategy that focuses on maintaining the critical physician-patient connection," said Jon Otterstatter, co-founder, president and CEO of Preventice. "The Preventice remote monitoring solutions together with the 2net Hub connectivity will not only allow providers to cost-effectively assess their patients' health and behaviors at any time, but it will further facilitate the secure data collection, transport and analysis essential to driving better health care outcomes and lowering costs."

Qualcomm Life's 2net Platform and Hub connects wireless medical devices via cloud-based solutions so that biometric information is easily accessible by device users, their health care providers and caregivers. The 2net Platform and Hub are intended to transfer, store, convert and display medical device data.

"The ability to store comprehensive patient data is an integral part of building mobile health applications and remote patient monitoring systems," said Rick Valencia, vice president and general manager of Qualcomm Life. "We are looking forward to working with Preventice to enhance connectivity and responsiveness of their offerings."

About Preventice

Preventice is a privately owned company and leading developer of mobile health applications and remote monitoring systems that connect mobile, home-based, and on-premise technologies to deliver continuous patient care across the health continuum—wherever an individual patient might be. Applications from Preventice create a constant connection and exchange of data between health care providers, life science companies and their patients. Current applications from Preventice address high-cost conditions and health management opportunities, including prescription medication management, cardiac care, sleep apnea, diabetes management, and migraine headaches. Preventice is headquartered in Minneapolis, with offices in Rochester, Minn., and Fargo, N.D. For more information, visit www.preventice.com.

Qualcomm is a registered trademark of Qualcomm Incorporated. 2net is a trademark of Qualcomm Incorporated. All other trademarks are the property of their respective owners.

For more information:

Colleen Kulhanek
+1-651-307-9486
Preventice

Barbara Tabor, APR
+1-651-230-9192
Tabor Communications Consulting for Preventice


'/>"/>
SOURCE Preventice
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. National Science Foundation grant expands UMCES oyster research
2. Research-based undergraduate course expands beyond Washington University
3. UNC expands brain imaging study of infants at risk for autism
4. Stowers Institutes Linheng Li Lab expands understanding of bone marrow stem cell niche
5. Springer expands its portfolio in plant sciences with Phytoparasitica
6. SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog
7. New book expands field data available on orangutans
8. Fetal alcohol syndrome testing expands
9. NIH expands Human Microbiome Project; funds sequencing centers and disease projects
10. Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line
11. ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... (PRWEB) , ... May 20, 2016 , ... The leading ... of its most experienced veterinary clients have treated over 100 of their own patients ... technology to provide the highest level of care for their patients. , The ...
(Date:5/20/2016)... ... May 20, 2016 , ... The recent recall by Costco and Trader ... Safety News on May 12, 2016(1), demonstrates the need for faster and more cost ... biotech firm, PathSensors, Inc. , PathSensor’s latest solution uses a biosensor ...
(Date:5/19/2016)... , May 19, 2016 ... will fully recover given the relentless pressures in pricing ... sure in the investors circle though - numerous opportunities ... Ahead of today,s session, ActiveWallSt.com,s presents four names in ... ), Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ), ...
(Date:5/19/2016)... May 19, 2016 - I ... orale durante il 52 ° ...    - Le conclusioni dello studio indicano ... pazienti trattati, di cui il 90% presenta una d ... o più. Il settantadue per cento dei pazienti ha riscontrato ...
Breaking Biology Technology: